Cell Source, Inc. Announces the Launch of Its New Investor Relations Website
The New IR Website Offers Investors Quick Access to Important Information While Maximizing Corporate Transparency
NEW YORK, NY -- (Marketwired) -- 05/22/15 -- Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, unveiled its new Investor Relations website. The site, (ir.cell-source.com), incorporates numerous features to make browsing for investment information a much faster and informative experience for the Company's current and potential investors.
The new Investor Relations section features immediate posting of the Company's press releases as they are issued, as well as the automated posting of SEC filings, XBRL data, Insider Section 16 filings and detailed annual as well as quarterly financial statements. Stock information data such as quotes, charts and historical prices are updated on demand with a 20-minute delay and the Company's financial tear sheet is updated daily after the market close. There is also an IR calendar featuring upcoming events, conference calls, investor presentations, CEO interviews and media coverage as well as corporate videos and an up-to-date frequently asked question section.
Itamar Shimrat, Cell Source, Inc.'s CEO said, "A significant part of our mission is presenting current and potential investors with the information they want in the quickest and most organized way. We believe our new IR website advances this goal by presenting our investor information in an attractive and easy-to-access format."
Mr. Shimrat continued, "A priority for the IR website is to maximize corporate transparency for the benefit of our investors and we are confident that the new IR website succeeds in providing this transparency. Furthermore, the IR website allows us to archive an extensive range of corporate materials and information that can be easily searched and accessed by any investor at any time."
Cell Source, Inc. engaged Equisolve, Inc. to design, develop and provide ongoing management for the new IR website. Equisolve is the leading company delivering cutting edge communications solutions for public companies by integrating the company's corporate website and IR website on a single platform.
Make sure you are first to receive timely information on Cell Source, Inc. when it hits the newswire. Sign up for Cell Source, Inc. email news alert system today at: ir.cell-source.com
Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of Cell Source, Inc. could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations, inability to hire and retain qualified personnel, and changes in the general economic climate, as well as the risk factors disclosed in Cell Source, Inc.'s Form 10-K filed on March 13, 2015. Cell Source, Inc. may, in some cases, use terms such as "anticipates," "continue," "estimates," "predicts," "believes," "potential," "proposed," "expects," "plans," "intends," "may," "could," "should," "might," "will," or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by Cell Source, Inc. or any other person, that such forward-looking statements will be achieved. Cell Source, Inc. undertakes no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity.
About Cell Source, Inc.
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine.
For more information go to www.cell-source.com
CELL SOURCE, INC.
INVESTOR, MEDIA & GENERAL CORPORATE CONTACT:
Phone: +1 (646) 612-7554
Toll Free: +1(888) 315-4650
Source: Cell Source, Inc.